Showing the single result
Retatrutide 20 mg Research Peptide – Lyophilized Vial
Retatrutide (LY3437943) is an investigational research peptide studied for its combined agonist activity at the GIP, GLP-1 and glucagon receptors. Supplied as a lyophilized powder in selectable 10 mg, 20 mg and 30 mg vial formats, it is intended for qualified laboratory, analytical and scientific research only.Product format: Lyophilized research peptide
Available vial contents: 20 mg
Research profile: GIP, GLP-1 and glucagon receptor agonist
Development code: LY3437943
Use restriction: Not for human or veterinary use